Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Antiretroviral Therapy
100%
Cerebrospinal Fluid
100%
MRNA Level
35%
CD4+ T
14%
AIDS/HIV
14%
Cell Count
14%
Suppressive Antiretroviral Therapy
14%
Immune Response
7%
Immune Status
7%
Plasma Samples
7%
Treatment Duration
7%
HIV-associated Neurocognitive Disorders
7%
Neurocognitive Function
7%
Compartmentalization
7%
Plasma Fluid
7%
Drug Distribution
7%
RNA Detection
7%
Central Nervous System Penetration Effectiveness Score
7%
Single-copy Assay
7%
Therapy Drugs
7%
Score-based Models
7%
Human Immunodeficiency Virus-associated Neurocognitive Disorder
7%
Neurocognitive Disorders
7%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Prevalence
100%
Cerebrospinal Fluid
100%
Ribonucleic Acid
100%
Blood Plasma
28%
Human Immunodeficiency Virus
28%
CD4 Lymphocyte Count
14%
Immune Response
7%
Central Nervous System
7%
Drug Distribution
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Human Immunodeficiency Virus 1
100%
HIV
21%
Disorders of Higher Cerebral Function
14%
HIV Associated Dementia
7%
Drug Distribution
7%
Neuroscience
Human Immunodeficiency Virus
100%
Blood Plasma
23%
CD4
11%
T Cell
11%
Central Nervous System
5%
HIV Associated Dementia
5%
Drug Therapy
5%